The FDA didn't make comment on efficacy.
They didn't say it was efficaious, nor did they say it wasn't. A lack of comment doesn't constitute an affirmative, although that's what people are implying.
What they did say is the trial was too deficient to consitute adequate evidence. So it's simply impossible to make any comment on efficacy without proper scientific evidence. When there is a properly controlled trial, then the FDA will comment on efficacy.
- Forums
- ASX - By Stock
- Crimes Against Humanity
The FDA didn't make comment on efficacy. They didn't say it was...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 39613 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | 1.565 |
3 | 15000 | 1.560 |
2 | 8950 | 1.545 |
3 | 52000 | 1.540 |
1 | 100000 | 1.525 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 14365 | 2 |
1.580 | 57756 | 6 |
1.585 | 5500 | 1 |
1.590 | 3123 | 1 |
1.600 | 5000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online